These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 39088109)
1. Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer's disease. Yan Y; Gao Y; Kumar G; Fang Q; Yan H; Zhang N; Zhang Y; Song L; Li J; Zheng Y; Zhang N; Zhang P; Ma C Metab Brain Dis; 2024 Oct; 39(7):1335-1351. PubMed ID: 39088109 [TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer's disease. Yan H; Yan Y; Gao Y; Zhang N; Kumar G; Fang Q; Li Z; Li J; Zhang Y; Song L; Wang J; Sun J; Zhang HT; Ma CG Sci Rep; 2022 Apr; 12(1):6625. PubMed ID: 35459923 [TBL] [Abstract][Full Text] [Related]
3. Fasudil ameliorates cognitive deficits, oxidative stress and neuronal apoptosis via inhibiting ROCK/MAPK and activating Nrf2 signalling pathways in APP/PS1 mice. Wei W; Wang Y; Zhang J; Gu Q; Liu X; Song L; Chai Z; Guo M; Yu J; Ma C Folia Neuropathol; 2021; 59(1):32-49. PubMed ID: 33969676 [TBL] [Abstract][Full Text] [Related]
4. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression. Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540 [TBL] [Abstract][Full Text] [Related]
5. [Fasudil improves cognitive function in APP/PS1 transgenic mice by promoting mitophagy and inhibiting NLRP3 inflammasome activation]. Liu H; Zhang P; Yu J; Wang J; Yu J; Guo M Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Aug; 40(8):696-703. PubMed ID: 39215667 [TBL] [Abstract][Full Text] [Related]
6. Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice. Yu JZ; Li YH; Liu CY; Wang Q; Gu QF; Wang HQ; Zhang GX; Xiao BG; Ma CG CNS Neurol Disord Drug Targets; 2017; 16(2):199-209. PubMed ID: 27401064 [TBL] [Abstract][Full Text] [Related]
7. Quercetin Attenuates Oxidative Stress and Apoptosis in Brain Tissue of APP/PS1 Double Transgenic AD Mice by Regulating Keap1/Nrf2/HO-1 Pathway to Improve Cognitive Impairment. Cheng M; Yuan C; Ju Y; Liu Y; Shi B; Yang Y; Jin S; He X; Zhang L; Min D Behav Neurol; 2024; 2024():5698119. PubMed ID: 39233848 [No Abstract] [Full Text] [Related]
8. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin. Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933 [TBL] [Abstract][Full Text] [Related]
9. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells. Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687 [TBL] [Abstract][Full Text] [Related]
10. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
12. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse. Hong H; Li Y; Su B J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435 [TBL] [Abstract][Full Text] [Related]
13. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q. Xu N; Li AD; Ji LL; Ye Y; Wang ZY; Tong L Eur J Histochem; 2019 May; 63(2):. PubMed ID: 31060348 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Rho Kinase by Fasudil Ameliorates Cognition Impairment in APP/PS1 Transgenic Mice via Modulation of Gut Microbiota and Metabolites. Yan Y; Gao Y; Fang Q; Zhang N; Kumar G; Yan H; Song L; Li J; Zhang Y; Sun J; Wang J; Zhao L; Skaggs K; Zhang HT; Ma CG Front Aging Neurosci; 2021; 13():755164. PubMed ID: 34721000 [No Abstract] [Full Text] [Related]
15. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521 [TBL] [Abstract][Full Text] [Related]
16. miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors. Xu Y; Chen P; Wang X; Yao J; Zhuang S Neurosci Lett; 2018 Mar; 670():94-104. PubMed ID: 29378298 [TBL] [Abstract][Full Text] [Related]
17. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease. Wang D; Fei Z; Luo S; Wang H Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672 [TBL] [Abstract][Full Text] [Related]
18. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice. Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800 [TBL] [Abstract][Full Text] [Related]
19. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease. Dong Z; Gu H; Guo Q; Liu X; Li F; Liu H; Sun L; Ma H; Zhao K Cells; 2022 Nov; 11(23):. PubMed ID: 36497090 [TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model. Chum PP; Hakim MA; Behringer EJ J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]